VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced the initiation of cell line development for its lead BiTAC ® T-cell engager ...

Genetic engineering could be used to develop new, more effective production systems for viral vector producing cell lines.

The House plans to vote Wednesday on a $425.1 million economic development package that carries over some of Gov. Maura Healey's priorities while adding a slew of new housing- and ...

Intravacc offers four complementary vaccine development platforms: bacterial vaccines, viral vaccines, conjugate vaccines, and E.coli expressed ...

Pierre-Alain Ruffieux, Cytiva’s group executive, bioprocess, discusses completion of the doubling of the company’s liquid ...

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive topline results from the Phase 3 MANGROVE study (BGB-3111-306; NCT04002297) evaluating ...

One receptor can protect antibodies from degradation, extend their half-life and become a drug target itself. Explore the ...

In a world first Australian researchers will test a one-off therapy that could repair damaged brain cells in people with ...

One of Northern California’s most popular party rivers is trying to curb dangerous summer chaos with a new $2 shuttle service ...

YOUNGSTOWN, Ohio (WKBN) – Multiple tornado and severe thunderstorm warnings were issued Sunday as two thunderstorms merged ...

The Supreme Court dealt Big Brother a blow on Monday with a landmark ruling for digital privacy rights in Chatrie v. United ...

Southern Wisconsin’s Fourth of July warmup turned into a race against the radar on Thursday evening, as a fast-moving line of severe thunderstorms barrelled east across the region and triggered a raft ...